Table 1.
Basic characteristics of the study population.
| Demographic data | N (64) |
|---|---|
| Age:(years) mean ± SD | |
| Sex: no (%) | 67.03 ± 5.9 |
| Female | 24 (37.5%) |
| Male | 40 (62.5%) |
| Body mass index (kg/m2): mean ± SD | 29.83 ± 4.41 |
| Body surface area (m2): mean ± SD | 1.88 ± 0.18 |
| Clinical data: no (%) | |
| Smoking | 26 (40.6%) |
| Hypertension | 54 (84.3%) |
| Diabetes | 18 (28.1%) |
| Previous stroke/TIA | 10 (15.6%) |
| Congestive heart failure | 34 (53.1%) |
| Vascular disease | 34 (53.1%) |
| Pacemaker or ICD | 8 (12.5%) |
| CHA2DS2-VASc (mean ± SD) | 3.66 ± 1.2 |
| Laboratory data (mean ± SD) | |
| Hemoglobin (g/dl) | 13.05 ± 1.46 |
| Platelet (103/μL) | 232.56 ± 51.85 |
| INR | 1.69 ± 0.57 |
| GFR (ml/min/1.73 m2) | 66.77 ± 17.51 |
| AF duration | |
| ⩽48 h | 15 (23.4%) |
| >48 h–1 week | 13 (20.3%) |
| >1 week–1 year | 17 (26.6%) |
| >1 year | 19 (29.7%) |
| Antithrombotic treatment | |
| Oral anticoagulation | 26 (40.6%) |
| Antiplatelet agents | 30 (46.9%) |
| Enoxaparine | 20 (31.1%) |
GFR: glomerular filtration rate, ICD: implantable cardioverter defibrillator, INR: international normalized ratio. TIA: transient ischemic attack. Vascular disease is defined as having at least one of the following: myocardial infarctions, peripheral artery disease, and complex aortic plaque.